Dictionary.com
Thesaurus.com
Showing results for agonist. Search instead for ago lost.

agonist

American  
[ag-uh-nist] / ˈæg ə nɪst /

noun

  1. a person engaged in a contest, conflict, struggle, etc., especially the protagonist in a literary work.

  2. a person who is torn by inner conflict.

  3. Physiology.  a contracting muscle whose action is opposed by another muscle.

  4. Pharmacology.  a chemical substance capable of activating a receptor to induce a full or partial pharmacological response.


agonist British  
/ ˈæɡənɪst /

noun

  1. any muscle that is opposed in action by another muscle Compare antagonist

  2. a competitor, as in an agon

"Collins English Dictionary — Complete & Unabridged" 2012 Digital Edition © William Collins Sons & Co. Ltd. 1979, 1986 © HarperCollins Publishers 1998, 2000, 2003, 2005, 2006, 2007, 2009, 2012

agonist Scientific  
/ ăgə-nĭst /
  1. A muscle that actively contracts to produce a desired movement.

  2. A chemical substance, especially a drug, that can combine with a receptor on a cell to produce a physiologic response.

  3. Compare antagonist


Etymology

Origin of agonist

First recorded in 1620–30; from Late Latin agōnista, from Greek agōnistḗs “contestant,” equivalent to agṓn agon + -istēs -ist

Example Sentences

Examples are provided to illustrate real-world usage of words in context. Any opinions expressed do not reflect the views of Dictionary.com.

That's because naloxone is a competitive receptor antagonist — the opposite of an agonist.

From Salon

And one item fit that bill: a new class of drugs — GLP-1 agonists, a type of medication that aids in weight loss but will likely have to be taken for long periods.

From Salon

Puberty blockers, or gonadotropin-releasing hormone agonists, were first approved by the U.S.

From Salon

These patients pay hundreds, if not thousands, of dollars to access new drugs, called GLP-1 agonists, along with online coaching to encourage healthy habits.

From Salon

The company appears most excited — judging from its messages to investors — about two experimental diabetes pills in the class known as GLP-1 agonists.

From Seattle Times